These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Ipilimumab treatment of metastatic melanoma].
    Author: Ghasemi H, Schmidt H, Stolle LB.
    Journal: Ugeskr Laeger; 2015 Jan 26; 177(2A):108-9. PubMed ID: 25612993.
    Abstract:
    Until recently metastatic melanoma was a disease with limited treatment options and a poor prognosis. However, new promising products have been developed. Ipilimumab, a full human anti-cytotoxic T-lymphocyte antigen-4 antibody, has shown improved survival in several clinical trials and is now a part of the standard treatment options for this disease in Denmark. In this case report we present a 78-year-old man with metastatic melanoma who had complete remission after treatment with ipilimumab.
    [Abstract] [Full Text] [Related] [New Search]